Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says
Executive Summary
The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says
You may also be interested in...
Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”
The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting
Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”
The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting
GAO Finds Hemophilia Rx Reimbursement Follows Familiar AWP Pattern
Hemophilia treatment centers purchase blood clotting factor from manufacturers at prices 35% to 48% below AWP, a General Accounting Office report states